130 related articles for article (PubMed ID: 15494296)
1. DNA methyltransferase inhibitors in myelodysplastic syndrome.
Silverman LR
Best Pract Res Clin Haematol; 2004 Dec; 17(4):585-94. PubMed ID: 15494296
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias.
Leone G; Teofili L; Voso MT; Lübbert M
Haematologica; 2002 Dec; 87(12):1324-41. PubMed ID: 12495905
[TBL] [Abstract][Full Text] [Related]
3. Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group.
Götze K; Platzbecker U; Giagounidis A; Haase D; Lübbert M; Aul C; Ganser A; Germing U; Hofmann WK
Ann Hematol; 2010 Sep; 89(9):841-50. PubMed ID: 20567826
[TBL] [Abstract][Full Text] [Related]
4. Methylation inhibitor therapy in the treatment of myelodysplastic syndrome.
Silverman LR; Mufti GJ
Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S12-23. PubMed ID: 16341236
[TBL] [Abstract][Full Text] [Related]
5. Targeting hypomethylation of DNA to achieve cellular differentiation in myelodysplastic syndromes (MDS).
Silverman LR
Oncologist; 2001; 6 Suppl 5():8-14. PubMed ID: 11700387
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with DNA methyltransferase inhibitors in hematologic malignancies.
Gore SD
Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S30-5. PubMed ID: 16341238
[TBL] [Abstract][Full Text] [Related]
7. New agents in myelodysplastic syndromes.
Jabbour EJ; Giles FJ
Curr Hematol Rep; 2005 May; 4(3):191-9. PubMed ID: 15865871
[TBL] [Abstract][Full Text] [Related]
8. An update on the treatment of myelodysplastic syndromes.
Kurtin SE; Demakos EP
Clin J Oncol Nurs; 2010 Jun; 14(3):E29-44. PubMed ID: 20529786
[TBL] [Abstract][Full Text] [Related]
9. Review of azacitidine trials in Intermediate-2-and High-risk myelodysplastic syndromes.
Fenaux P; Ades L
Leuk Res; 2009 Dec; 33 Suppl 2():S7-11. PubMed ID: 20004796
[TBL] [Abstract][Full Text] [Related]
10. [Epigenetic therapy in myelodysplastic syndromes (MDS). Treatment with DNA methyltransferase inhibitors].
Daskalakis M; Blagitko-Dorfs N; Hackanson B; Lübbert M
Pharm Unserer Zeit; 2010 May; 39(3):217-27. PubMed ID: 20425776
[No Abstract] [Full Text] [Related]
11. Hypomethylating agents in myelodysplastic syndromes changing the inevitable: the value of azacitidine as maintenance therapy, effects on transfusion and combination with other agents.
Silverman LR
Leuk Res; 2009 Dec; 33 Suppl 2():S18-21. PubMed ID: 20004792
[TBL] [Abstract][Full Text] [Related]
12. 5-azacitidine: An alternative treatment of myelodysplastic syndromes in patient with refractory response to hematopoietic growth factor, a case report and review of literatures.
Suwanawiboon B; Sumida KN
Hawaii Med J; 2004 Jan; 63(1):14-6, 25. PubMed ID: 15011897
[TBL] [Abstract][Full Text] [Related]
13. Clinical roundtable monograph. Overall survival and maintenance of MDS patients.
Silverman LR
Clin Adv Hematol Oncol; 2009 Jul; 7(7):S3-5. PubMed ID: 19708287
[TBL] [Abstract][Full Text] [Related]
14. Novel agents for the management of myelodysplastic syndromes.
Meletis J; Viniou N; Terpos E
Med Sci Monit; 2006 Sep; 12(9):RA194-206. PubMed ID: 16940944
[TBL] [Abstract][Full Text] [Related]
15. Advances in myelodysplastic syndrome: nursing implications of azacitidine.
Demakos EP; Linebaugh JA
Clin J Oncol Nurs; 2005 Aug; 9(4):417-23. PubMed ID: 16117208
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of signaling in myelodysplastic syndrome.
Gore SD
Best Pract Res Clin Haematol; 2004 Dec; 17(4):613-22. PubMed ID: 15494298
[TBL] [Abstract][Full Text] [Related]
17. Translational research in myelodysplastic syndromes.
Raza A; Qawi H; Mehdi M; Mumtaz M; Galili N
Rev Clin Exp Hematol; 2004 Dec; 8(2):E2. PubMed ID: 16027100
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside analogs and antimetabolite therapies for myelodysplastic syndrome.
Foss FM
Best Pract Res Clin Haematol; 2004 Dec; 17(4):573-84. PubMed ID: 15494295
[TBL] [Abstract][Full Text] [Related]
19. Incorporating novel agents in the treatment of myelodysplastic syndromes.
Anargyrou K; Vassilakopoulos TP; Angelopoulou MK; Terpos E
Leuk Res; 2010 Jan; 34(1):6-17. PubMed ID: 19656566
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation changes following 5-azacitidine treatment in patients with myelodysplastic syndrome.
Tran HT; Kim HN; Lee IK; Kim YK; Ahn JS; Yang DH; Lee JJ; Kim HJ
J Korean Med Sci; 2011 Feb; 26(2):207-13. PubMed ID: 21286011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
